News | December 17, 2023
Panacea Biotec launches EasyFourPol in India
Receives registration of Valganciclovir powder for oral solution in Germany
Receives registration of Valganciclovir powder for oral solution in Germany
“One Earth, One Health” vision can become a reality only with active global collaboration where countries don’t think of only themselves, but of collective global outcomes
This donation will allow the continuation of the cycle of vaccination for children foreseen within the national immunization program carried out by the Ministry of Public Health of Cuba
UNICEF award is worth US $98.755 million for supply of around 99.70 million doses during calendar years 2023-2027
Mankind Pharma has agreed to retain Panacea Biotec’s sales and marketing team engaged in this business
CEPI is accelerating its programme to develop broadly protective coronavirus vaccines—a core part of US $ 3.5 billion pandemic preparedness plan
The batch will be distributed in India through a partner of RDIF and Panacea Biotec - Dr. Reddy's Laboratories
The said batches have successfully passed all the checks for quality parameters both at the Gamaleya Center in Russia and at the Central Drug Laboratory, Kasauli in India
First batch produced at Panacea Biotec’s facilities at Baddi will be shipped to the Gamaleya Center for quality control and full scale production of the vaccine is due to start this summer
Production of Sputnik V at Panacea Biotec sites will help facilitate global supply of Sputnik V to international partners of RDIF
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)